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Abstract
Digital Breast Tomosynthesis (DBT) is an X-ray mammography technique where multiple low-dose projection images of the breast are reconstructed in multiple 
tomographic images creating a semi-3D mammogram. This enables the visualization of a sequential set of thin sections of the breast, overcoming the masking effect 
of overlying fibroglandular breast tissue, then improving carcinoma detection and reducing false-positive cases. This review aims at describing current DBT technique, 
analyzing DBT in clinical practice and providing an overview of published studies on clinical experience with DBT in the screening and diagnostic settings.
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Introduction
Screening asymptomatic women for breast cancer with 
mammography can reduce cancer-related mortality up to 30%, since 
breast carcinoma is a progressive disease and early detection enables 
better prognosis [1-7].  However, evidence suggests that 15-30% of breast 
cancers are missed by standard screening mammography, and this rate 
can be even higher in women under 50 years [8] and in women with 
dense breast [9-12]. In fact, the primary limitation of mammography is 
the overlapping of dense fibroglandular breast tissue that can decrease 
the visibility or hide underlying malignant lesion [13-16].
Moreover, the overlay of normal fibroglandular breast tissue 
may mimic the appearance of carcinoma, leading to a reduction in 
specificity and increase in false-positive recalls [16]. In the early 2000s, 
mammography has transitioned from film-screen system to digital 
detectors [17,18], with an improved diagnostic performance, especially 
in women with dense breasts [19]. The introduction of full field digital 
mammography (FFDM) has also allowed the development of new 
diagnostic breast techniques like digital breast tomosynthesis (DBT).
DBT is an X-ray mammography technique where multiple low-dose 
projection images of the breast are acquired moving the X-ray tube in 
an arc over a limited angular range, and subsequently reconstructed 
in multiple tomographic images creating a pseudo-3D mammogram 
[20, 21]. Such acquisition enables the visualization of a sequential set 
of thin sections of the breast, allowing overcomes the masking effect of 
overlapping fibroglandular tissue, improving carcinoma detection and 
reducing the number of false-positives [21].
This technique showed better sensitivity and specificity compared 
to FFDM, especially for detection of non-calcified breast cancer [22] 
and it has been proven to be an efficient tool either in screening and 
diagnostic settings, since its introduction in the clinical setting after the 
approval by the Food and Drug Administration (FDA) in 2011.
DBT provides pseudo-3D images allowing a more detailed 
delineation of breast lesion contour, enhancing the visualization of 
distortions and also providing an accurate localization and extension of 
breast lesions, in addition to possible identification of additional cancer 
foci [23]. This article describes the current available DBT technique 
and provides an overview of the state of the art in both screening and 
diagnostic clinical settings.
Technique
The breast is compressed and held between the compression 
paddle and the detector, as in performing FFDM. The x-ray tube moves 
across a limited arc above the breast, acquiring a sequence of low-dose 
exposures at preset intervals, each from a different angle, resulting in 
a series of projection images [24-26]. The angle range (from 15 to 50° 
[20]), the tube motion, the arc length and the time needed to obtain 
a whole set of projection images vary among different manufacturers 
[27,28] (Table 1).
In the post processing, raw data from DBT projections can be 
reconstructed to obtain a series of images of the whole breast, typically 
with 1 mm spacing, parallel to the DBT platform plane [29]: this process 
allows a pseudo-3D evaluation of breast tissue distribution. Due to the 
limited angle of the projections, DBT has a high spatial resolution in 
the plane parallel to the detector, but a lower spatial resolution in the 
perpendicular direction [28]; however, spatial resolution in the depth 
direction is sufficient to reduce the effects of breast tissue overlapping 
[29,30]. 
The tomographic slices are then displayed on the tomosynthesis 
vendor’s proprietary workstation or PACS for radiological 
interpretation; the total number of reconstructed images depends on 
the thickness of the compressed breast and is equal to the thickness of 
patient's breast plus five additional slices, that are added to each set of 
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images to the image non-receptor side to help define the breast edges. 
The reader can scroll through the images manually or in a dynamic cine 
mode, and change the section thickness.
The image quality of DBT is highly dependent on the geometry of 
the system and on the choice of optimal acquisition, reconstruction, 
and display parameters.
Dose
DBT images can be acquired by using an FDA-approved combined 
acquisition mode [31] that is FFDM and DBT performed during the 
same examination: DBT projection images are carried out first, and 
then standard mammographic images are obtained in a perpendicular 
position, with no modifications of breast compression, or in an 
independent acquisition.
DBT images are low-dose, with a mean glandular doses (MGD) of 
an average-sized breasts of about 2.3 mGy per view, which is about 1 
to 1.5-times higher than the dose per view for FFDM [32]; the use in 
combination of FFDM and DBT doubles approximately the radiation 
dose [33], therefore, the radiation exposure is one of the main concerns 
of DBT, especially when using DBT in any program of population 
screening, also considering that radiation dose is cumulative over time. 
In a phantom study on radiation exposure from DBT, Feng and 
Sechopoulos [34] demonstrated a MGD range of 0.309 - 5.26 mGy for 
a single caudocranial view acquisition in FFDM mode and of 0.657 - 
3.52 mGy for the DBT mode acquisition; for a breast with a compressed 
thickness of 5 cm and 50% glandular fraction, the MGD of DBT was 
only 8% higher than that of FFDM acquisition (1.30 and 1.20 mGy, 
respectively, per view), while, for a breast with a compressed thickness 
of 6 cm and glandular fraction of 14.3%, the DBT resulted in a 83% 
higher MGD compared to FFDM (2.12 versus 1.16 mGy): therefore the 
range of radiation dose is highly variable, depending on breast size and 
composition.
MGD is also strongly influenced by some characteristics of the DBT 
system such as detection process (direct/indirect), scan angle, number 
of projections, tube motion and reconstruction algorithms, with a large 
variability among the investigated systems [35], but in any case the dose 
remains below the FFDM threshold limits established by the European 
Reference Organization for Quality Assured Breast Screening and 
Diagnostic Service [36].
The DBT examination may be performed using different 
combinations [21, 37], including 2-view DBT plus 2-view FFDM or 
single-view DBT plus single-view FFDM [38, 39], and varies among 
vendors; the use of a single-view DBT reduces the MGD [39-42]. 
Acquisition of standard mammogram is needed to have a panoramic 
view of the breast and for comparison with previous and future studies, 
so there is wide consensus that the only DBT images are not enough.
To overcome the dose issue, manufacturers have developed a 
synthesized mammography (SM) that provides the benefits of a 
combined FFDM plus DBT examination with a reduced radiation 
exposure; this is a synthesized 2D image generated from the DBT data. 
SM is a maximum intensity projection (MIP) of frequency-weighted 
reconstructions created by concentrating the tomosynthesis image set 
to a single 2D image [43]. In May 2013, the FDA approved the use of 
SM in combination with DBT to reduce the total radiation exposure by 
approximately 45% [43].
SM is now considered a valid alternative for FFDM: its aim is to 
provide the 2D component of the DBT examination, particularly 
useful when comparing with previous [44]. In SM, algorithms preserve 
imaging characteristics such as microcalcifications and spiculations but 
with poorer overall resolution and increased image noise [45]. Recent 
studies showed that the screening performances of SM plus DBT are 
not inferior to those achieved with FFDM plus DBT [46] and it is likely 
that SM will replace FFDM in the near future, with a remarkable dose 
reduction.
Additional reading time
The interpretation of a DBT examination consists of the evaluation 
of the 2D mammography plus the analysis of the DBT dataset, with 
a variable number of slices, depending on patient’s breast thickness: 
the largest number of images to read in comparison to the only FFDM 
causes an increase of the interpretation time. Studies have shown that 
interpretation time for 2D plus DBT is about twice that of conventional 
mammography [47]. Skaane et al. [48] reported reading times of 45 
seconds for conventional mammography and 91 seconds for DBT; 
Wallis et al. [40] confirmed an approximate doubling in the reading time 
with an average time of 67 seconds for conventional mammography 
and of 124 seconds for DBT. Zuley et al. [49] described an increase in 
reading time of about 33%.
The extra reading time will obviously impact on radiologist’s 
activity and has a significant relevance in high workloads of screening 
examinations, but the increased time for images interpretation could be 
potentially compensated by time saved in the workflow management, 
Manufacturer HOLOGIC GE Healthcare SiemensHealthcare FUJI
Internazionale Medico 
Scientifica
Model Selenia Dimensions Seno Claire MAMMOMAT Inspiration Amulet Innovality Giotto
Scanning Angle° 15 25 50 40 HR15 ST 20
Projection 15 9 25 15 13
Scanning Time (sec) 4 7 24 9 HR4 ST 12
Tube Motion continuous step and shoot continuous* continuous Healthcare
Detector Material a Se a Si/Csl a Se a Se a Se
Reconstruction Algorithm FBP Iterative FBP FBP Iterative
FBP = Filtered Back Projections
ST = Standard Mode
HR = High Resolution Mode
a Se = amorphous selenium
a Si/Csl = amorphous silicon/cesium iodine
*Continuous scanning mode with short pulses of radiation
Table 1. Characteristics of Clinical DBT Systems
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as already reported [48, 50-55], for instance reducing the recall rate in 
screening setting.
Information Technology storage and connectivity
Information technology (IT), image storage, retrieval systems and 
workstation requirements are important issues when introducing DBT 
in clinical practice [21, 55]. DBT images require a large amount of 
storage space, especially in screening programs, due to the high numbers 
of participating women and considering that storage requirements will 
increase with time as more patients will have previous DBT studies for 
comparison.
DBT image files size are 10–20 times that of 2D conventional 
mammography; the number of slices for each DBT set depends on the 
breast thickness, but an average combined DBT/FFDM study is about 
1GB of data, which could be reduced to approximately 250 MB if the 
DBT images are stored with a 4:1 reversible (lossless) compression 
[40,55].
Before introducing DBT in clinical practice, it is also important to 
account that workstation requirements for reading tomosynthesis could 
be different from 2D FFDM, since standard workstations may not have 
sufficient random access memory to display DBT. Workstations for 
DBT analysis require all the standards needed for FFDM reading (i.e.: 
high resolution monitor, customized visualization protocols, image 
resizing tools, image annotation, computer-aided detection marks), but 
also rapid scrolling, cine capacity and the possibility to visualize 2D and 
synthesized 2D and DBT images [21].
Clinical applications for DBT 
In clinical practice, 2 sets of DBT are usually acquired for each 
breast: the cranio-caudal projection and the medio-lateral oblique 
projection, as usually performed in conventional mammography. The 
use of two-view DBT combined with two-view FFDM allows obtaining 
the best diagnostic accuracy; the availability of 2-view FFDM is useful 
for the accurate detection and characterization of microcalcifications 
and comparison with previous [28, 56,57].
In symptomatic patients, presenting with palpable lump, nipple 
discharge, skin thickening and/or nipple retraction, DBT demonstrated 
a diagnostic accuracy equivalent or superior to conventional 
mammography [58, 59] and some studies stated that DBT had the 
advantage to replace additional spot compression mammography, 
having the same diagnostic accuracy, and to reduce the use of other 
diagnostic techniques, such as ultrasound and MRI [58-61]. Moreover, 
recent studies demonstrated that DBT in the diagnostic settings 
decreased the number of lesions classified as BI-RADS category 3, 
particularly masses and asymmetric lesions, with a substantial increase 
in the number of those categorized as BI-RADS 1, 2, or 5 [62].
In the screening setting, DBT plus FFDM versus FFDM alone 
showed overall improved accuracy [47], especially in women with 
scattered and heterogeneous breast densities [63]. Particularly, DBT 
can provide benefits in some diagnostic contexts: as lobular carcinoma, 
that is often difficult to detect on FFDM due to its linear pattern of 
growing without a typical mass shape (Figure 1). Also breast cysts and 
fibroadenomas are better identified and characterized by DBT than 
FFDM because their shape and margins are generally better defined in 
the DBT images as oval or round circumscribed masses with smooth 
margins. Dermal and vascular calcifications, surgical scars and intra-
mammary lymph nodes are other common findings, better visible and 
adequately assessed by DBT [64] (Figure 2). 
Due to its greater sensitivity for benign lesions, the introduction 
of DBT in a FFDM-based screening could lead to a recall rate increase 
related to previously undetected benign masses; for this reason, the 
overall screening recall rate reduction, seen with the implementation 
of DBT, is primarily due to more accurate assessment of summation 
shadows and pseudo lesions [21].
Malignant tumors can be better detected by tomosynthesis when 
compared with FFDM alone; the standard DBT views show precise 
details of the tumor, highlighting suspicious irregular shapes, indistinct 
or spiculated margins and other important features, particularly in 
cancers surrounded by normal fibroglandular tissue (Figures 3-6).
Staging
Mammographic evaluation of breast cancer should include lesion 
size, number of lesions, and the assessment of contralateral disease. 
DBT is a valuable tool for breast cancer staging due to its ability to 
detect multifocal or contralateral disease and its accuracy of lesion 
measurement. Lesion size evaluation at FFDM can be challenging and 
usually this feature is better assessed at US or MRI [65]. The tumor is 
depicted in multiple images at DBT and, only the core nucleus of the 
mass in the slice with the best cancer visualization should be measured 
in order to assess the actual tumor size, avoiding the spicules that may 
be seen on other sections [28]. Several studies have shown that this 
approach correlates well with pathologic analysis in masses measuring 
up to 20 mm and is more accurate than FFDM alone [66]. Due to the 
possibility of having a greater visualization of details, DBT can depict 
Figure 1. Asymptomatic 67-year-old woman with no family history of breast cancer, with a partially hidden, subtle, irregular shaped mass in the upper external quadrant of the left breast 
DBT allowed the detection of a 3 cm high-grade invasive lobular carcinoma. The lesion was measured more precisely on DBT than on ultrasound
1A left MLO FFDM, 1B left CC FFDM, 1C left CC DBT, 1D left US 
A B C D
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Figure 2. 53-year-old woman with left nipple bloody discharge, I grade family history of ovarian cancer and a personal history of left breast lumpectomy for fibroadenoma. No previous 
examinations were available
2A left CC FFDC, 2B left CC DBT (at upper quadrants), 2C left CC DBT (at equatorial line)
The circle in 2B indicates a cyst, with smooth, well-defined margins, better depicted in DBT.
The rectangle in 2C shows the scar of the previous lumpectomy.
The arrow in 2C indicates a 1.5 cm mid-grade invasive ductal adenocarcinoma
A B C
A B
Figure 3. Clear visualization of an architectural distortion at DBT in a 45-year old asymptomatic woman, with no family history of breast cancer, at her first routine screening mammography
3A left ML FFDM, 3B left ML DBT
The presence of a parenchymal distortion, located in the central pre-pectoral breast area, is well visible on DBT, in a heterogeneously dense breast. The lesion was occult on ultrasound and 
tomosynthesis-guided Vacuum Assisted Breast Biopsy was performed and demonstrated invasive ductal carcinoma with ductal carcinoma in situ
Figure 4. Detection of a small mass at DBT in heterogeneously dense breast, in a 49-year-old asymptomatic woman due to the better visibility of surrounding spicules in DBT images
4A right MLO FFDM, 4B right MLO DBT, 4C right US of the lesion
US-guided core needle biopsy proved an invasive ductal carcinoma
A B C
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Figure 5. DBT showed a mass associated with an architectural distortion in the periareolar infero-external quadrant of heterogeneously dense right breast of a 45-year-old asymptomatic 
woman, with a recent ultrasound diagnosis of ill-defined hypoechoic area, non-palpable at clinical examination
5A right CC FFDM, 5B right MLO FFDM, 5C right CC DBT, 5D right US of the hypoechoic area.
Invasive ductal carcinoma with ductal carcinoma in situ was diagnosed with US-guided core needle biopsy
A B C D
Figure 6. DBT showing a low-density oval mass in a 67-year-old asymptomatic woman with fatty breast 
6A right MLO FFDM, 6B right MLO DBT, 6C right US of the lesion
US-guided core needle biopsy demonstrated low-grade invasive ductal carcinoma
A B C
additional satellite lesions, in multifocal disease, that can change 
patient management (Figure 7). There is evidence supporting that the 
use of DBT in the evaluation of the contralateral breast in women with 
newly diagnosed breast cancer could represent a faster, less invasive 
and more economical way compared to MRI, which now represents 
the gold standard in detecting contralateral cancer (Figure 8) [28].  
In the next section, we provide an overview of the DBT appearance 
of the most common features related to malignancy.
Architectural distortion
Architectural distortion is a subtle imaging finding, usually better 
detected at DBT than at FFDM, frequently recognizable on only one 
view; it may be similar in density to surrounding tissue and may have 
areas of associated fat. The detection of architectural distortions is 
important due to its known positive predictive value for breast cancer 
[50,67,68]. In clinical practice, DBT is useful for the evaluation of 
potential architectural distortion, allowing a better detection of the 
radiating lines that converge to a point, especially along a fat-glandular 
interface and at the apex of the breast, where summation is common 
[28] (Figure 3). Careful scrolling through a suspected architectural 
distortion on DBT may also reveal an associated mass previously 
undetected by FFDM (Figure 5). In a study by Dang PA et al. [57], 
common presentations of cancers on tomosynthesis were irregular 
spiculated masses (61%, 105/172), architectural distortion (12%, 
20/172), and lobulated circumscribed masses (8%, 13/172). Of the 
cancers presenting as architectural distortion on tomosynthesis, 50% 
(10/20) were occult on conventional mammography and 20% (4/20) 
were characterized as asymmetry or focal asymmetry on conventional 
mammography. Cancers presenting as architectural distortion on 
tomosynthesis had a disproportionately higher percentage of ILCs 
(20%). 
Radial scars, post-biopsy and post-surgical scars can be detectable 
as architectural distortions and may be better visible at DBT than on 
FFDM (Figure 2). When an architectural distortion is detected, an 
accurate review of breast clinical history is needed: without a correlative 
surgical history, image-guided biopsy of architectural distortion is often 
warranted because benign and malignant architectural distortions are 
indistinguishable [50].
Focal asymmetry
Focal asymmetry is an area of tissue visible on two views in the 
same breast, unilateral, without a correlate of tissue in the same 
position of the contralateral breast; it has similar shape on different 
mammographic projections, but without the conspicuity or the borders 
of a mass [69]. DBT is useful to confirm and characterize this finding 
as a true asymmetry, dismiss it as a superimposition, or reclassify it 
as a mass. In a study by El Maadawy et al. [70] the authors used DBT 
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for evaluation of focal mammographic asymmetry and DBT showed 
higher sensitivity (93.8%) for lesion visualization and differentiation 
from summation artifacts in comparison to spot compression imaging 
(50.2 %).
Masses
Masses are characterized by their shape, margin and density. DBT 
can depict shape and edges with precise details, underlying a suspicious 
irregular shape, indistinct or spiculated margins. Zuley et al. [49], 
found that the use of the word “irregular”, as shape adjective, decreased 
significantly at DBT especially for benign lesions, reclassified at DBT as 
lobulated or oval.
In some cases, the only clues leading to the detection of a subtle 
malignant mass are fine spiculations presenting as thin isodense 
lines secondary to straightening of adjacent fibroglandular tissue and 
Cooper ligaments: these features are often better depicted at DBT [71], 
in particular for cancers surrounded by normal fibroglandular tissue, in 
heterogeneously dense breasts [12] (Figures 4 and 5).
Moreover, DBT can depict iso- or hypodense masses: this is 
particularly relevant because some cancers are characterized by 
intratumoral fat, entrapped or absorbed from the surrounding adipose 
tissue during growth, and appear less radiopaque and badly outlined in 
FFDM, even in low density breasts [72] (Figure 6). 
Figure 7. Asymptomatic 79-year-old woman with fatty breast, with two suspicious masses / architectural distortions in the left breast at FFDM
7A left MLO FFDM, 7B left MLO DBT, 7C left US of the two biggest lesions 
US confirmed the two lesions visualized at FFDM.
DBT was able to detect another small suspicious lesion in the same breast.
A B C
A B C D
E F G
Figure 8. Asymptomatic 55-year-old woman with fatty breast tissue, recalled from FFDM screening for microcalcifications in the left fatty glandular breast. No previous exams available
8A right MLO FFDM, 8B left MLO FFDM, 8C right MLO DBT, 8D left MLO DBT, 8E left US of lesion 1, 8F left US of lesion 2, 8G right US of lesion 3.
MLO FFDM images showed in the left breast (B) two small clusters of microcalcifications associated with architectural distortions.
MLO DBT images (C, D) detected multifocal bilateral disease, with depiction of a small spiculated mass in the contralateral right breast (lesion 3).
US modality (E, F, G) confirmed as suspicious all the three lesions.
US-guided core needle biopsy proved multifocal bilateral invasive ductal carcinoma
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Microcalcifications
Microcalcifications can be the early and unique sign of breast 
carcinoma. There are many reports regarding the ability of DBT to 
visualize microcalcifications in comparison with FFDM that is the 
actual gold standard. Poplack and colleagues [73] compared FFDM 
with DBT in the evaluation of different lesion subtypes and observed 
that microcalcification showed better image quality on diagnostic 
mammography than on tomosynthesis. On the other hand, Kopans and 
colleagues [74] compared the clarity of microcalcifications on FFDM 
and DBT, observing that microcalcifications were seen on DBT with 
better accuracy in 41.6% of the cases, with equivalent accuracy in 50.4% 
and only in 8% of cases were better seen on FFDM.
Spangler and colleagues [75] demonstrated a statistically significant 
higher detection rate for calcifications on FFDM than DBT (84% vs 
75%) and higher specificity in evaluating the calcifications (71% vs 
64%). Indeed, if calcifications are small and spread, single reconstructed 
DBT slices may show only few calcifications of a clinically significant 
cluster, not allowing a correct spatial evaluation. If calcifications are 
large, they may produce significant artifacts, appearing on multiple 
slices as repeating ghost-like, out-of-focus, white objects bordered by 
dark shadows, marching in the direction of the x-ray tube motion [56].
New perspectives
Nowadays, studies are focused on evaluating the diagnostic 
performance of tomosynthesis in screening setting; one example is 
The Mammographic Imaging Screening Trial (TMIST), which is a 
randomized breast cancer screening trial that compares FFDM with 
DBT. The Eastern Cooperative Oncology Group (ECOG) and the 
American College of Radiology Imaging Network (ACRIN) Cancer 
Research Group opened the trial on July 6, 2017, and plans to enroll 
about 165,000 women, aged 45-74 years, by the end of 2020 [76].
One of the major concerns that limit the use of DBT, especially 
as a screening tool, is the radiant exposure: the introduction of new 
reconstruction algorithms can potentially solve this issue. There is 
evidence suggesting that the use of iterative reconstructions allows 
to obtain better contrast, better image quality, optimal visibility of 
calcifications and fewer artifacts, compared to traditional filtered back 
projection reconstructions [77] and to get a better contrast-to-noise 
ratio with the same radiation dose [78,79].
Further developments are also expected in the area of computer-
aided detection (CAD): recent studies showed that CAD allows a 
non-inferiority of reader interpretation performance, with a faster 
reading time.  The introduction of CAD in clinical practice would allow 
overcoming a limit of tomosynthesis that is the additional reading time 
[80,81].
Another important innovation is the development of new 
equipment, like the combination of DBT with automated breast 
ultrasound: its goal is to implement sensitivity in patients with dense 
breast; currently, to our knowledge, there are only few data available on 
small groups of patients in this setting [82,83], but this new technologies 
would seem to provide promising results.
Conclusions
Since its recent introduction, DBT is rapidly emerging as a 
practice changing technique. It improves the accuracy of clinical 
mammography, by increasing sensitivity and specificity; particularly in 
screening patients, DBT reduces the recall rates and increases cancer 
detection. It is a useful tool for further characterization of suspicious 
findings, improving reading confidence and diagnostic accuracy and 
for local staging of breast cancer, thus implementing surgical planning.
Although additional data from large multicenter prospective trials 
and further analysis on cost effectiveness are needed, this technology 
provides improvement of mammographic imaging and more efficient 
diagnostic workups.
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